摘要
目的研究法尼基转移酶抑制剂FTI-277单独或联合三氧化二砷(As2O3)对急性髓系白血病(AML)细胞增生和凋亡的影响及其作用机制。方法以HL-60细胞株、31例初治AML患者骨髓标本为研究对象,用四甲基偶氮唑蓝(MTT)法检测细胞增生,用流式细胞术检测细胞周期、磷酸化ERK1/2表达,用AnnexinV-FITC法、DNA琼脂糖凝胶电泳检测细胞凋亡。结果FTT-277可明显抑制AML细胞增生,对正常细胞无明显抑制增生作用。FTI-277使AML细胞G2/M期百分数显著升高,但亚G1期细胞百分数无明显变化。FTI-277显著下调AML细胞磷酸化ERK1/2的表达,但不影响正常细胞表达。联合组与单用组相比,AML细胞凋亡率明显增高,并可检出梯状DNA条带。结论FTI—277通过阻断AML细胞ERK/MAPK途径,使细胞发生G2/M期阻滞,抑制细胞增生。FTI-277可增强As2O3对AML细胞的凋亡诱导作用。
Objective To investigate the mechanisms of farnesyhransferase inhibitor FTI-277 inhibiting proliferation of acute myeloid leukemia (AML) cells and enhancing apoptosis induced by As2O3. Methods HL-60 cells and bone marrow mononuclear cells (BMMNCs) from 31 AML patients at diagnosis were examined. Cell proliferation was determined by MTT test. Cell cycle and the expression of phospho-ERK1/2 were detected by flow cytometry. Cell apoptosis was determined by DNA agrose gel electrophoresis and annexinV-FiTC/PI double-staining. Results FTI-277 inhibited proliferation of AML cells. However, this inhibitor had little effect on proliferation of normal cells. Incubation with FTI-277 led to an increase of AML cells in G2/M, whereas the sub-G1 fraction remained unchanged. Incubation of AML cells with FTI-277 decreased the expression of phospho-ERK1/2, where the expression of phospho-ERK1/2 in normal cells were unaffected by FTI-277. In the combination group, the percentage of apoptosis was increased with increasing concentration of FTI-277 and the apoptosis ladders were readily observed. Furthermore, FTI-277 and As2O3 in combination significantly induced apoptosis of AML cells compared with either FTI-277 or As2O3. Conclusion FTI-277 exerts proliferation inhibition on AML cells by inhibiting constitutive ERK/MAPK activation and resulting in a G2/M block. FTI-277 doesn't inhibit proliferation of normal cells with low steady-state levels of ERK/MAPK activity. FTI-277 can enhance apoptosis induced by As2O3.
出处
《白血病.淋巴瘤》
CAS
2007年第1期19-22,共4页
Journal of Leukemia & Lymphoma